ストックスクリーナーアプリを入手
4.86
7.95%
-0.42
アフターアワーズ：
4.83
-0.03
-0.62%
Optimizerx Corp (OPRX) 最新ニュース
OptimizeRx price target lowered to $13 from $17 at B. Riley - Yahoo Finance
Lake Street reiterates Buy on OptimizeRx after ‘surprising’ CEO departure - Yahoo Finance
OptimizeRx’s (OPRX) Buy Rating Reaffirmed at Lake Street Capital - Defense World
OptimizeRx (NASDAQ:OPRX) Given New $13.00 Price Target at B. Riley - Defense World
Stifel maintains Buy rating on OptimizeRX stock citing shift to consistent growth strategy - Investing.com India
Lake Street holds OptimizeRX stock at Buy list despite CEO exit - Investing.com Australia
OptimizeRx's (OPRX) Buy Rating Reaffirmed at Lake Street Capital - MarketBeat
Lake Street holds OptimizeRX stock at Buy list despite CEO exit By Investing.com - Investing.com South Africa
OptimizeRx Corp. Announces Chief Executive Officer Changes - Marketscreener.com
OptimizeRX stock retains Buy rating as company transitions to new leadership team - Investing.com
OptimizeRx CEO to step down, interim successor named By Investing.com - Investing.com Australia
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO - EIN News
OptimizeRx CEO to step down, interim successor named - Investing.com
OptimizeRx CEO Steps Down After 9-Year Growth Era; Company Projects Strong 2024 Outlook - StockTitan
OptimizeRx (NASDAQ:OPRX) Research Coverage Started at Stephens - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Stake Increased by BNP Paribas Financial Markets - Defense World
Stephens & Co. Initiates Coverage of OptimizeRx (OPRX) with Equal-Weight Recommendation - MSN
The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts - Benzinga
OptimizeRx (NASDAQ:OPRX) Earns Equal Weight Rating from Analysts at Stephens - MarketBeat
OptimizeRx CEO William Febbo acquires $100,220 in company shares By Investing.com - Investing.com Australia
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles By Investing.com - Investing.com Canada
OptimizeRx's SWOT analysis: digital health stock faces growth hurdles - Investing.com
OptimizeRx Co. (NASDAQ:OPRX) CEO William J. Febbo Purchases 20,000 Shares - MarketBeat
OptimizeRx CEO William Febbo acquires $100,220 in company shares - Investing.com
OptimizeRx's SWOT analysis: digital health firm's stock faces growth hurdles - Investing.com
AWM Investment Company, Inc. Reduces Stake in OptimizeRx Corp - GuruFocus.com
Quest Partners LLC Buys 9,739 Shares of OptimizeRx Co. (NASDAQ:OPRX) - Defense World
US Penny Stocks To Watch In November 2024 - Simply Wall St
OptimizeRx (OPRX) Surges 19.8%: Is This an Indication of Further Gains? - MSN
OptimizeRx to Participate in Upcoming Investor Conferences - The Manila Times
OptimizeRx to Present at ROTH and Canaccord Genuity Healthcare Conferences in NYC | OPRX Stock News - StockTitan
Janney Montgomery Scott LLC Buys Shares of 104,917 OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Brokerages Set OptimizeRx Co. (NASDAQ:OPRX) Price Target at $11.58 - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Earnings Call Transcript - Insider Monkey
AWM Investment Company's Strategic Acquisition of OptimizeRx Cor - GuruFocus.com
Divisadero Street Capital Management's Strategic Acquisition of OptimizeRx Shares - GuruFocus.com
OptimizeRX shares target cut, maintains buy rating on lower revenue - Investing.com
OptimizeRx's (OPRX) "Buy" Rating Reiterated at Roth Mkm - MarketBeat
Optimizerx stock hits 52-week low at $4.69 amid market challenges - Investing.com Nigeria
Earnings call: OptimizeRx reports 30% revenue growth in Q3 By Investing.com - Investing.com UK
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $8.00 by Analysts at Stifel Nicolaus - MarketBeat
JMP Securities Lowers OptimizeRx (NASDAQ:OPRX) Price Target to $8.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Given New $5.00 Price Target at Barclays - MarketBeat
OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates - MSN
OptimizeRx Reports Third Quarter 2024 Financial Results - The Manila Times
OptimizeRx Corp (OPRX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Shifts ... By GuruFocus - Investing.com Canada
Earnings call: OptimizeRx reports 30% revenue growth in Q3 - Investing.com India
OPTIMIZERx earnings beat by $0.06, revenue fell short of estimates - Investing.com
OptimizeRx Q3 Revenue Jumps 30% to $21.3M, Updates 2024 Guidance | OPRX Stock News - StockTitan
OptimizeRx (OPRX) Scheduled to Post Earnings on Wednesday - Defense World
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Wednesday - Defense World
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Rice Hall James & Associates LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizRx stock hits 52-week low at $5.42 amid market challenges - Investing.com India
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET - The Manila Times
0.00%
0.32%
大文字化:
|
ボリューム (24 時間):